JPRN-UMIN000004223已完成2 期
Feasibility study of Neoadjuvant chemoradiotherapy for locally advanced esophageal carcinoma - NeoCRT trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)active other malignancies within 5 years 2)Pregnant or lactating women, women who are capable of pregnancy or intend to get pregnant, men who don't intend to have protected intercourse. 3)Unsuitable mental status and condition for clinical trials. 4)Patients who received ontinuous steroids (orally or intravenous) administration. 5)Positive HBsAg. 6)Unstable diabetes mellitus with oral hypoglycemic agent or insulin. 7)Acute myocardial infarction within 3 months 8)severe complications (COPD, interstitial lung disease, pulmonary fibrosis, heart failure and so on) 9)clinically significant infectious disease(body temperature less than 38.0 degrees) 10)Any other cases who are regarded as inadequate for study enrollment by the investigator.
研究者
相似试验
已完成
不适用
Feasibility study of neoadjuvant chemoradiotherapy using Intensity Modulated Radiation Therapy (IMRT) with Docetaxel, CDDP and 5-Fluorouracil (DCF) for cervical esophageal cancer.cervical esophageal cancerJPRN-UMIN000018241Gunma University Hospital6
已完成
不适用
Feasibility trial of neoadjuvant chemoradiotherapy in patients with locally advanced gastric cancerGastric cancerJPRN-UMIN000004960Department of Gastroenterological Surgery, School of Medicine, Kagawa University16
已完成
不适用
Feasibility study of neoadjuvant chemotherapy with docetaxel/CDGP/5-fluorouracil in resectable esophagus canceresophagus cancerJPRN-UMIN000014305Department of Medical Oncology, Sapporo Medical University School of Medicine28
招募中
不适用
A feasibility study of neoadjuvant chemotherapy with mFOLFOX6 in patients with locally metastatic rectal cancerrectal cancerJPRN-UMIN000003428Toho University school of medicine20
已完成
不适用
A feasibility study of neoadjuvant chemotherapy with docetaxel+cisplatin+capecitabine (DCX) for HER2-negative gastric cancer with macroscopic type 4 and large type 3, or with multiple lymph node metastasisGastric cancerJPRN-UMIN000026783agoya University20